DK1545548T3 - Anvendelsen af kombinationen af ciclesonid og antihistaminer til behandingen af allergisk rhinitis - Google Patents

Anvendelsen af kombinationen af ciclesonid og antihistaminer til behandingen af allergisk rhinitis

Info

Publication number
DK1545548T3
DK1545548T3 DK03755551.3T DK03755551T DK1545548T3 DK 1545548 T3 DK1545548 T3 DK 1545548T3 DK 03755551 T DK03755551 T DK 03755551T DK 1545548 T3 DK1545548 T3 DK 1545548T3
Authority
DK
Denmark
Prior art keywords
ciclesonide
antihistamines
combination
treatment
allergic rhinitis
Prior art date
Application number
DK03755551.3T
Other languages
English (en)
Inventor
Degenhard Marx
Helgert Mueller
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Application granted granted Critical
Publication of DK1545548T3 publication Critical patent/DK1545548T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK03755551.3T 2002-08-30 2003-08-29 Anvendelsen af kombinationen af ciclesonid og antihistaminer til behandingen af allergisk rhinitis DK1545548T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02019406 2002-08-30
PCT/EP2003/009622 WO2004019955A1 (en) 2002-08-30 2003-08-29 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis

Publications (1)

Publication Number Publication Date
DK1545548T3 true DK1545548T3 (da) 2010-09-27

Family

ID=31970274

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03755551.3T DK1545548T3 (da) 2002-08-30 2003-08-29 Anvendelsen af kombinationen af ciclesonid og antihistaminer til behandingen af allergisk rhinitis

Country Status (21)

Country Link
US (2) US7879832B2 (da)
EP (2) EP2295062B1 (da)
JP (2) JP4746318B2 (da)
KR (1) KR101067795B1 (da)
CN (1) CN1674916A (da)
AT (1) ATE472329T1 (da)
AU (1) AU2003273396B2 (da)
BR (2) BR0313611A (da)
CA (1) CA2495830C (da)
DE (1) DE60333205D1 (da)
DK (1) DK1545548T3 (da)
ES (2) ES2348034T3 (da)
IL (1) IL166483A (da)
MX (1) MXPA05001885A (da)
NO (1) NO335400B1 (da)
NZ (1) NZ538954A (da)
PL (1) PL373433A1 (da)
PT (1) PT1545548E (da)
SI (1) SI1545548T1 (da)
WO (1) WO2004019955A1 (da)
ZA (1) ZA200500719B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2004052374A1 (en) * 2002-12-12 2004-06-24 Altana Pharma Ag Combination medicament
EP1635845A1 (en) * 2003-06-13 2006-03-22 ALTANA Pharma AG Formoterol and ciclesonide combination
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
HUE030388T2 (en) 2004-11-24 2017-05-29 Meda Pharmaceuticals Inc Preparations and methods of use containing azelastine
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
WO2006097458A1 (en) * 2005-03-15 2006-09-21 Nycomed Gmbh Novel combination
US20080311196A1 (en) * 2006-07-13 2008-12-18 White Donna F All Day Rhinitic Condition Treatment Regimen
US20080015241A1 (en) * 2006-07-13 2008-01-17 Cornerstone Biopharma, Inc. All day rhinitic condition treatment regimen
JP5661985B2 (ja) * 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
KR100878698B1 (ko) * 2007-04-05 2009-01-13 한미약품 주식회사 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및이를 포함하는 약학 조성물
CA2813748C (en) * 2010-10-06 2016-06-14 Ista Pharmaceuticals, Inc. Bepotastine compositions
PL2736491T3 (pl) * 2011-01-04 2017-09-29 Bausch & Lomb Incorporated Kompozycje bepotastyny
CN105307655B (zh) 2013-03-13 2019-05-03 弗拉特利发现实验室有限责任公司 哒嗪酮化合物及其用于制备治疗囊肿状纤维化的药物的应用
CN106692115A (zh) * 2015-11-13 2017-05-24 天津金耀集团有限公司 一种环索奈德混悬鼻喷剂组合物

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (da) * 1963-04-24
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
US4369184A (en) 1980-01-24 1983-01-18 Janssen Pharmaceutica N.V. 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
ES2053678T3 (es) * 1987-11-13 1994-08-01 Asta Medica Ag Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
DE59407183D1 (de) * 1993-04-02 1998-12-03 Byk Gulden Lomberg Chem Fab Neue prednisolonderivate
EP0709099A3 (en) 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
WO1997001341A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal mast cell stabilizers and topical nasal steroids
EP0780127A1 (en) 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
CA2256721A1 (en) 1996-06-04 1997-12-11 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
FR2754712B1 (fr) * 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
US20020111495A1 (en) * 1997-04-04 2002-08-15 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
EP0979105A1 (en) 1997-04-30 2000-02-16 Warner-Lambert Company Topical nasal antiinflammatory compositions
EP0903151A1 (en) 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6297227B1 (en) * 1998-09-10 2001-10-02 Schering Corporation Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
DE19947234A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
KR20010089887A (ko) 1999-10-20 2001-10-12 야스이 쇼사꾸 수성의약품 조성물
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US20040097486A1 (en) * 1999-11-18 2004-05-20 Yanni John M. Use of an H1 antagonist and a safe steroid to treat eye conditions
CN1376066A (zh) 1999-11-18 2002-10-23 爱尔康公司 H1拮抗剂和安全类固醇的治疗眼病的用途
US6653313B2 (en) * 2000-08-10 2003-11-25 Warner-Lambert Company Llc 1,4-dihydropyridine compounds as bradykinin antagonists
US6706726B2 (en) * 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
CA2468749A1 (en) 2001-12-05 2003-06-19 Alcon, Inc. Use of an h1 antagonist and a safe steroid to treat rhinitis
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
EP1560586A1 (en) * 2002-11-12 2005-08-10 Alcon, Inc. The use of an anti-allergy agent and a steroid to treat allergic rhinitis

Also Published As

Publication number Publication date
IL166483A (en) 2013-11-28
CN1674916A (zh) 2005-09-28
PT1545548E (pt) 2010-09-02
EP2295062A1 (en) 2011-03-16
US8486923B2 (en) 2013-07-16
EP2295062B1 (en) 2012-08-29
KR101067795B1 (ko) 2011-09-27
KR20050058400A (ko) 2005-06-16
NZ538954A (en) 2007-04-27
ZA200500719B (en) 2006-02-22
SI1545548T1 (sl) 2010-11-30
JP4746318B2 (ja) 2011-08-10
AU2003273396A1 (en) 2004-03-19
PL373433A1 (en) 2005-08-22
WO2004019955A1 (en) 2004-03-11
BRPI0313611B1 (pt) 2018-03-06
US7879832B2 (en) 2011-02-01
NO335400B1 (no) 2014-12-08
ATE472329T1 (de) 2010-07-15
BR0313611A (pt) 2005-06-21
MXPA05001885A (es) 2005-06-03
EP1545548B1 (en) 2010-06-30
ES2348034T3 (es) 2010-11-29
ES2393864T3 (es) 2012-12-28
AU2003273396B2 (en) 2008-12-11
EP1545548A1 (en) 2005-06-29
US20050245493A1 (en) 2005-11-03
JP2005539044A (ja) 2005-12-22
DE60333205D1 (de) 2010-08-12
CA2495830C (en) 2012-08-21
CA2495830A1 (en) 2004-03-11
IL166483A0 (en) 2006-01-15
JP2011021043A (ja) 2011-02-03
NO20051521L (no) 2005-03-22
US20110092471A1 (en) 2011-04-21
NO20051521D0 (no) 2005-03-22

Similar Documents

Publication Publication Date Title
NO20051521D0 (no) Anvendelse av kombinasjonen av ciclesonid og antihistaminer for behandlingen av allergisk rhinitt
DK1423381T3 (da) 17beta-hydroxysteroid-dehydrogenase type 3-inhibitorer til behandling af androgenafhængige sygdomme
DK1663978T3 (da) Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
DK2298338T3 (da) Lactoferrin-sammensætninger og fremgangsmåder til behandling af hudsår
DK2700309T3 (da) Sammensætninger omfattende et kollagenbiovæv til anvendelse ved behandling af sygdomme og lidelser
DK1673104T3 (da) Fremføring af terapeutiske forbindelser til hjernen og andre væv
DE60322582D1 (de) Oberflächenbehandlung von medizinischem gerät
DK1855677T3 (da) 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser
FI20060154A (fi) Neurogeneratiivisten tilojen hoito
NO20076206L (no) Kombinasjon av PDE4 inhibitor romflumilast og et tetrahydrobioterin-derivativ
DE60231295D1 (de) R und ppar modulatoren
DE60237725D1 (de) Vervendung von dexrazoxane in der prävention und behandlung der alzeheimer-krankheit
NO20070988L (no) Vaksine for forebygging og behandling av HIV-infeksjon
DK1506041T3 (da) Inbandronsyre til behandling og forebyggelse af osteoporose
NO20045554L (no) Fremgangsmate for behandling av diabetes
DK1478438T3 (da) Fremgangsmåder og sammensætninger til behandling af astma
ATE469886T1 (de) 17beta-hydroxysteroid dehydrogenase typ-3 hemmer zur behandlung von androgen abhängigen erkrankungen
DK1670482T4 (da) Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
DK1727801T3 (da) Til behandling af smerter anvendelige piperaziner
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
NO20054700L (no) Anvendelse av et fibrat og orlistat for behandling av fedme
DK1569634T3 (da) Anvendelse af en PPAR-agonist og metformin til behandling af fedme
DK1530462T3 (da) 1-phenyl-2-dimethylaminomethylcyclohexanforbindelser til behandling af depressionssymtomer. smerte og inkontinens
DK2845594T3 (da) Anvendelse af dihydroimidazoloner til behandlingen af hunde.
ATE369136T1 (de) Therapeutische behandlung